• Home
  • Global Regulatory Affairs Services
    • Introduction
    • Pharmaceutical
      • Requirements of Health Authorities
      • Drug Application Process
      • Meeting with Health Authorities
      • Electronic Common Technical Document (eCTD)
      • Register of Innovative Drugs
      • Submissions Comparing to Innovative Drugs
      • Product Monograph
      • Drug Label Compliance
      • Filing of Information and Material to Health Authorities
      • Evaluation of Submissions
      • Pharmacovigilance
    • Natural Health Products
      • NHP Documentation Review
      • NHP Product Registration Submissions
      • Natural Health Product Site Licence
    • Medical Device
      • Medical Devices Services
      • Medical Device Application Process
      • Medical Device class II, III and IV
  • Market Expansion Services
  • Contact Us
Atinza Canada Inc.Atinza Canada Inc.
  • Home
  • Global Regulatory Affairs Services
    • Introduction
    • Pharmaceutical
      • Requirements of Health Authorities
      • Drug Application Process
      • Meeting with Health Authorities
      • Electronic Common Technical Document (eCTD)
      • Register of Innovative Drugs
      • Submissions Comparing to Innovative Drugs
      • Product Monograph
      • Drug Label Compliance
      • Filing of Information and Material to Health Authorities
      • Evaluation of Submissions
      • Pharmacovigilance
    • Natural Health Products
      • NHP Documentation Review
      • NHP Product Registration Submissions
      • Natural Health Product Site Licence
    • Medical Device
      • Medical Devices Services
      • Medical Device Application Process
      • Medical Device class II, III and IV
  • Market Expansion Services
  • Contact Us

Filing of Information and Material to Health Canada

Home PharmaceuticalFiling of Information and Material to Health Canada

All information and material and responses to clarification requests

Except Clinical Trial Applications and Amendments

to be sent via courier to the Submission and Information Policy Division (SIPD)

Atinza can prepare package and sent to SIPD on behalf of clients. We will also control the dispatch of documents and following the process of evaluation by Health Canada. We will also response to Notices (including Screening Deficiency Notices, Notices of Non-Compliance, Notices of Deficiency) on behalf of clients.

CTAs, CTA-As

Clinical Trial Applications and Amendments

to be sent via courier to the appropriate Bureau/Centre, Biologics and Genetic Therapies Directorate or Therapeutic Products Directorate.

Atinza will support clients to ensure compliance with “Guidance for Clinical Trial Sponsors – Clinical Trial Applications“. We will also control the dispatch of documents and following the process of evaluation by Health Canada. We will also response to Notices on behalf of clients.

Contact Us

Please let us know if you have any inquiries.

Send Message
Global Expertise in Regulatory Affairs Experienced & Results-Oriented

© [2017] — Atinza Canada Inc. All rights reserved.